BAG3 and myofibrillar myopathy: Importantly, the p.Trp2710Ter-induced aggregate blocks autophagy through BAG3 recruitment to the aggregate, suggesting that both BAG3 reduction and autophagy promotion as potential therapies for FLNC p.Trp2710Ter myofibrillar myopathy [14].